Work

MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e15169

Authors: Diane Lauren Reidy, Olca Basturk, Anuja Kriplani, Ghassan K. Abou-Alfa, William R. Jarnagin, Peter J. Allen, Leonard Saltz, David S. Klimstra, Liying Zhang

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907992987

Cites:

Cited by: 4

Related to: 10